Saved in:
| Main Author: | |
|---|---|
| Format: | Artículo científico |
| Language: | en |
| Published: |
Centro de investigaciones y Publicaciones Farmacéuticas
2011
|
| Subjects: | |
| Online Access: | https://www.redalyc.org/articulo.oa?id=69022231007 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1866811825131094016 |
|---|---|
| author | Michael J. CAWLEY |
| author_facet | Michael J. CAWLEY |
| contents | Assessment of a pharmacist-driven point-of-care spirometry clinic within a primary care physicians office Michael J. CAWLEY Richard PACITTI William WARNING Medicina of Point Spirometry Pharmacists Care Systems Objective, To assess value-added service of apharmacist-driven point-of-care spirometry clinic to quantify respiratory disease abnormalities within a primary care physicians office Methods, This retrospective, cohort study was an analysis of physician referred patients who attended our spirometry clinic during 2008-2010 due to pulmonary symptoms or disease. After spirometry testing, data was collected retrospectively to include patient demographics, spirometry results, and pulmonary pharmaceutical interventions. Abnormal spirometry was identified as an obstructive and/or restrictive defect. Results, Sixty-five patients with a primary diagnosis of cough, shortness of breath, or diagnosis of asthma or chronic obstructive pulmonary disease were referred to the spirometry clinic for evaluation. A total of 51 (32 patients with normal spirometry, 19 abnormal spirometry) completed their scheduled appointment. Calculated lung age was lower in normal spirometry (58.1, SD=20 yrs) than abnormal spirometry (78.2, SD=7.5 yrs, p<0.001). Smoking pack years was also lower in normal spirometry (14.4, SD=10.7 yrs) than abnormal spirometry (32.7, SD=19.5 yrs, p=0.004). Resting oxygen saturation of the arterial blood (SaO2) was higher in normal spirometry than abnormal spirometry (98.1%vs 96.5%, p=0.016). Mean change in the forced expiratory volume in one second (FEV1) after administration of bronchodilator was greater in patients with abnormal spirometry compared with normal spirometry (10.9% vs 4.1%, p<0.001). Spirometry testing assisted in addition, discontinuation or altering pulmonary drug regimens in 41/51 patients (80%) and the need for further diagnostic testing or physician referral in 14/51 patients (27.4%). Conclusion, Implementation of a pharmacist-driven spirometry clinic is a value-added service that can be integrated with other clinical pharmacy services within the ambulatory care setting. Further studies are needed to determine the role of pharmacists inperforming spirometry testing and measuring performance outcomes of the pulmonary patient. 2011 artículo científico 1885-642X https://www.redalyc.org/articulo.oa?id=69022231007 en http://www.redalyc.org/revista.oa?id=690 Pharmacy Practice application/pdf Centro de investigaciones y Publicaciones Farmacéuticas Pharmacy Practice (España) Num.4 Vol.9 |
| format | Artículo científico |
| id | redalyc_69022231007 |
| language | en |
| publishDate | 2011 |
| publisher | Centro de investigaciones y Publicaciones Farmacéuticas |
| spellingShingle | Assessment of a pharmacist-driven point-of-care spirometry clinic within a primary care physicians office Michael J. CAWLEY Medicina of Point Spirometry Pharmacists Care Systems Assessment of a pharmacist-driven point-of-care spirometry clinic within a primary care physicians office Michael J. CAWLEY Richard PACITTI William WARNING Medicina of Point Spirometry Pharmacists Care Systems Objective, To assess value-added service of apharmacist-driven point-of-care spirometry clinic to quantify respiratory disease abnormalities within a primary care physicians office Methods, This retrospective, cohort study was an analysis of physician referred patients who attended our spirometry clinic during 2008-2010 due to pulmonary symptoms or disease. After spirometry testing, data was collected retrospectively to include patient demographics, spirometry results, and pulmonary pharmaceutical interventions. Abnormal spirometry was identified as an obstructive and/or restrictive defect. Results, Sixty-five patients with a primary diagnosis of cough, shortness of breath, or diagnosis of asthma or chronic obstructive pulmonary disease were referred to the spirometry clinic for evaluation. A total of 51 (32 patients with normal spirometry, 19 abnormal spirometry) completed their scheduled appointment. Calculated lung age was lower in normal spirometry (58.1, SD=20 yrs) than abnormal spirometry (78.2, SD=7.5 yrs, p<0.001). Smoking pack years was also lower in normal spirometry (14.4, SD=10.7 yrs) than abnormal spirometry (32.7, SD=19.5 yrs, p=0.004). Resting oxygen saturation of the arterial blood (SaO2) was higher in normal spirometry than abnormal spirometry (98.1%vs 96.5%, p=0.016). Mean change in the forced expiratory volume in one second (FEV1) after administration of bronchodilator was greater in patients with abnormal spirometry compared with normal spirometry (10.9% vs 4.1%, p<0.001). Spirometry testing assisted in addition, discontinuation or altering pulmonary drug regimens in 41/51 patients (80%) and the need for further diagnostic testing or physician referral in 14/51 patients (27.4%). Conclusion, Implementation of a pharmacist-driven spirometry clinic is a value-added service that can be integrated with other clinical pharmacy services within the ambulatory care setting. Further studies are needed to determine the role of pharmacists inperforming spirometry testing and measuring performance outcomes of the pulmonary patient. 2011 artículo científico 1885-642X https://www.redalyc.org/articulo.oa?id=69022231007 en http://www.redalyc.org/revista.oa?id=690 Pharmacy Practice application/pdf Centro de investigaciones y Publicaciones Farmacéuticas Pharmacy Practice (España) Num.4 Vol.9 |
| title | Assessment of a pharmacist-driven point-of-care spirometry clinic within a primary care physicians office |
| topic | Medicina of Point Spirometry Pharmacists Care Systems |
| url | https://www.redalyc.org/articulo.oa?id=69022231007 |